Sensors and smartphones aim to capture the unseen fluctuations of Muscle-Weakening disease
NCT ID NCT07226830
Summary
This study aims to see if wearable sensors and smartphone apps can effectively track the day-to-day symptoms of generalized myasthenia gravis (gMG), a disease that causes muscle weakness. It will observe 25 people with gMG for 16 weeks as they start a standard treatment, using devices to monitor their movement, speech, and fatigue at home. The goal is to find better, more continuous ways to measure this fluctuating condition compared to occasional clinic visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS GENERALIZED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital, Neuromuscular Diagnostic Center
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.